Society of Interventional Radiology Issues Position Statement to Guide Use of Life-Saving Endovascular Interventions in Trauma Care

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

“Endovascular intervention plays a critical role in the care of the trauma patient, improving survival, reducing morbidity and decreasing blood loss,” said SIR President Laura Findeiss, MD, FSIR. “When delivered promptly, it is highly effective in treating bleeds throughout the body, including in the liver, spleen, kidneys and pelvis—saving lives and saving function.”

View the full position statement here.

While traumatic injury is the leading cause of death for people younger than 45, the mortality rates have dropped due to better integration of multidisciplinary care, faster access to advanced imaging and interventions, and use of non-operative management in specific scenarios.

“This position statement sets out important recommendations to ensure that the appropriate level of knowledge and expertise are available among all members of the trauma team to ensure that the right care is delivered as swiftly as possible,” Findeiss said.

Among the recommendations offered in the position statement:

  • Immediate 24-hour access to an interventional angiography facility
  • A multidisciplinary team that includes specialists who can perform larger and small vessel endovascular interventions
  • The ability for an interventional team to be ready to intervene within 60 minutes from the time a multidisciplinary team decides to proceed with an endovascular intervention
  • The development and adherence to evidence-based treatment algorithms for each trauma scenario for both adults and children
spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.